Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Angler101on May 03, 2023 5:58pm
142 Views
Post# 35428661

RE:RE:Partnerships...

RE:RE:Partnerships...Quentin.....oh wise one.....did you ever stop to think that it was BECAUSE you (and others like you) sold for a profit, that the price quit rising, and any potential new buyers see the curve flattening and then falling and then they back off, volume drops, and so on. Another issue that seems to have escaped you is that now, to get back in, you’ll have to pay a premium that cuts into your “40% profit” while those that hung on will still be making very close to the same profit without having to go to the trouble of sitting and watching it every day. Plus, if big buyers step in, and they will, you might end up chasing it and having to buy in at a price that not only obliterates your puny little extra profit, but costs  you much more .......so good luck, but please spare us your bragging, because for one, you haven’t told us how many shares you supposedly bought, so it could be 200, or maybe even 5000, (I’m guessing the lower , otherwise you wouldn’t be yapping about it like an excited teenager) and secondly, if you do miss the boat, there’s not a chance in hell you’ll be here admitting it.
<< Previous
Bullboard Posts
Next >>